Article
CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
The pharmacogenomics journal - 1 Feb 2013
White C C, Feng Q, Cupples L A, Gainer J V, Dawson E P, Wilke R A, Brown N J
Abstract excerpt
The ω-hydroxylase CYP4A11 catalyzes the transformation of epoxyeicosatrienoic acids (EETs) to ω-hydroxylated EETs, endogenous peroxisome proliferator-activated receptor-α (PPARα) agonists. PPARα activation increases high-density lipoprotein cholesterol (HDL-C). A cytosine-for-thymidine (T8590C) variant of CYP4A11 encodes for an ω-hydroxylase with reduced activity. This study examined the relationship between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
